Results 41 to 50 of about 3,763,730 (308)

A Narrative Review of Nutritional Therapy for Gastrointestinal Cancer Patients Underwent Surgery

Journal of Investigative Surgery, 2023
Background: Patients with gastrointestinal cancer often suffer from malnutrition during tumor progression. Malnutrition is associated with postoperative complications and decreased quality of life.
Yujie Zhang, Jinglin Zhang, Lili Zhu, Jiaqi Hao, Fengjun He, Tao Xu, Rui Wang, Wen Zhuang, Mojin Wang   +8 more
doaj   +1 more source

Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination

, 2023
Gastric cancer is heterogeneous in morphology, biology, genomics, and treatment response. Alterations in human epidermal growth factor receptor 2 (HER2) overexpression, microsatellite instability (MSI) status, programmed death-ligand 1 (PD-L1) levels ...
라선영, 정현철, Sun Young Rha, Hyun Cheol Chung   +3 more
core   +1 more source

Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center

BMC Cancer, 2018
Background Greater lymph node retrieval in gastric cancer improves staging accuracy and may improve survival from increased clearance of nodal micrometastasis.
Shiela S. Macalindong, Kwang Hee Kim, Byung-Ho Nam, Keun Won Ryu, Norihito Kubo, Ja Yeon Kim, Bang Wool Eom, Hong Man Yoon, Myeong-Cherl Kook, Il Ju Choi, Young Woo Kim   +10 more
doaj   +1 more source

The impact of hiatal hernia on survival outcomes in patients with gastroesophageal junction adenocarcinoma

Annals of Gastroenterological Surgery, 2022
Aim A hiatal hernia (HH) complicates the diagnosis and surgical treatment of gastroesophageal junction (GEJ) cancer. This study aimed to investigate the effect of HH on the survival outcomes of GEJ cancer patients.
Yuya Tanaka, Takahiro Kinoshita, Eigo Akimoto, Reo Sato, Masahiro Yura, Junichiro Harada, Mitsumasa Yoshida, Yoshiaki Tomi   +7 more
doaj   +1 more source

Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study [PDF]

, 2015
PURPOSE: The purpose of this pilot study was to evaluate the association between adenosine triphosphate-based chemotherapy response assays (ATP-CRAs) and subsets of tumor infiltrating lymphocytes (TILs) in gastric cancer. MATERIALS AND METHODS: In total,
김충배, 손태일, 이지연, 형우진, 정재호, 노성훈, 김형일   +6 more
core   +1 more source

Recurrence after ESD curative resection for early gastric cancer

Surgical Case Reports, 2021
Background Endoscopic submucosal dissection (ESD) is gaining ground as a minimally invasive treatment for early gastric cancer (EGC) that has a negligible risk of lymph node metastasis.
Ayako Kamiya, Hitoshi Katai, Kenichi Ishizu, Takeyuki Wada, Tsutomu Hayashi, Sho Otsuki, Yukinori Yamagata, Takaki Yoshikawa, Shigeki Sekine, Tomohiko Nishi, Yuka Kawasaki, Takafumi Ito, Hideharu Domoto   +12 more
doaj   +1 more source

Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gatric cardia cancer. [PDF]

, 2008
<b>INTRODUCTION</b> Atrophic gastritis is a risk factor for non-cardia gastric cancer, and gastro-oesophageal reflux disease (GORD) for oesophageal adenocarcinoma.
Didevar, R., Derakhshan, M.H., Watabe, H., Yazdanbod, A., Rakhshani, N., Zolfeghari, A., McColl, K.E.L., Zolfeghari, A.A., Fyfe, V., Sotoudeh, M., Malekzadeh, R., Kazemi, A.   +11 more
core   +1 more source

Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification

Gut and Liver, 2017
Background/AimsDelayed bleeding after gastric endoscopic submucosal dissection (ESD) commonly occurs within 3 days, but it may also occur after 1 week following ESD, especially in antiplatelet agent users.
Jong Yeul Lee, Chan Gyoo Kim, Soo-Jeong Cho, Young-Il Kim, Il Ju Choi   +4 more
doaj   +1 more source

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells

MedComm, 2023
Drug resistance remains the greatest challenge in improving outcomes for cancer patients who receive chemotherapy and targeted therapy. Surmounting evidence suggests that a subpopulation of cancer cells could escape intense selective drug treatment by ...
Xiaohai Song, Yang Lan, Xiuli Zheng, Qianyu Zhu, Xuliang Liao, Kai Liu, Weihan Zhang, QiangBo Peng, Yunfeng Zhu, Linyong Zhao, Xiaolong Chen, Yang Shu, Kun Yang, Jiankun Hu   +13 more
doaj   +1 more source

Clinical Outcomes of Endoscopic Hemostasis for Bleeding in Patients with Unresectable Advanced Gastric Cancer [PDF]

, 2017
Purpose: Bleeding is one of the most serious complications of advanced gastric cancer (AGC) and is associated with a poor prognosis. This study aimed to evaluate the clinical outcomes of endoscopic hemostasis for bleeding in patients with unresectable ...
정현수, 김현주, 이용찬, 송인지, 신성관, 박준철, 이상길   +6 more
core   +1 more source